# Jasper Therapeutics, Inc.: Form 8-K, filed Dec 29, 2020

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2020-12-29
- Accepted by EDGAR: Dec 29, 2020, 06:12 ET
- Period: 2020-12-22
- Accession: 0001213900-20-045061
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390020045061/ea132310-8k_amplitude.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390020045061/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390020045061/ea132310-8k_amplitude.htm

Filed Dec 29, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-045061. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.